Investment Rating - The report maintains a "Buy" rating for the company [5][7]. Core Insights - The company's overall performance in Q1 2025 is subdued, but the key growth driver for 2025 is expected to be offline distribution, with a focus on increasing the proportion of daily sales products and sales performance [5]. - The company achieved revenue of 10.622 billion yuan in 2024, representing a year-on-year growth of 49.30%, and a net profit attributable to shareholders of 408 million yuan, up 85.51% year-on-year [5]. - In Q1 2025, the company reported revenue of 3.723 billion yuan, a slight increase of 2.13% year-on-year, but net profit decreased by 22.46% year-on-year to 239 million yuan [5]. Revenue Breakdown - Online channels, particularly through Douyin, saw rapid growth, with 2024 online revenue reaching 7.407 billion yuan, a year-on-year increase of 49.60%, accounting for approximately 70% of total revenue [2]. - Offline distribution also expanded significantly, with offline channel revenue reaching 3.215 billion yuan in 2024, a year-on-year growth of 48.62% [2]. - The main brand, Three Squirrels, generated revenue of 9.825 billion yuan in 2024, reflecting a year-on-year growth of 50.57% [3]. Profitability Analysis - The gross margin for 2024 was 24.25%, an increase of 0.92 percentage points year-on-year, attributed to scale effects and an increase in self-produced products [4]. - The net profit margin for 2024 was 3.84%, up 0.75 percentage points year-on-year [4]. - In Q1 2025, the gross margin was 26.74%, showing stability despite a slight decrease of 0.66 percentage points year-on-year [4]. Future Projections - The company is expected to achieve revenues of 13.522 billion yuan, 16.972 billion yuan, and 20.160 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 27.3%, 25.52%, and 18.78% [5][12]. - The projected net profit for 2025 is 450 million yuan, with a year-on-year growth of 10.41% [5][12].

Investment Rating - The investment rating for the company is "Buy" [5] Core Views - The company's performance is expected to improve as impairment impacts have bottomed out, with potential growth in the coal machinery and oil and gas sectors [1] - The company reported a 42.9% year-on-year decrease in net profit for 2024, primarily due to goodwill impairment in oil and gas equipment and inventory impairment in real estate [2] - The revenue structure has changed significantly, with a notable decline in profitability due to one-time impairments and reduced profitability in oil and gas equipment [3] Summary by Sections Domestic and International Development - Domestic demand has shown fluctuations, but there is significant potential for diversified development both domestically and internationally. The mining equipment sector is expected to benefit from increased industry concentration, while the logistics equipment sector is gaining overseas orders [1] - The company has expanded into emerging fields, including robotics and new energy equipment, which are expected to provide ongoing growth momentum [1] Financial Performance - For 2024, the company achieved a revenue of 21.9 billion yuan, an 8% increase year-on-year, with overseas revenue growing by 28.4% to 8.17 billion yuan. However, net profit decreased to 1.1 billion yuan, a 42.9% decline [2] - The gross margin for 2024 was reported at 22.4%, down 4.4 percentage points year-on-year, while the net margin was 4.9%, down 4.2 percentage points [3] Profitability Forecast - The company is expected to see a recovery in performance starting in 2025, with projected revenues of 24.2 billion yuan, 29.5 billion yuan, and 33.9 billion yuan for 2025, 2026, and 2027 respectively, reflecting a CAGR of 18% [4] - The forecasted net profits for the same years are 2.19 billion yuan, 2.65 billion yuan, and 2.99 billion yuan, with a CAGR of 17% [4]

Investment Rating - The report gives a "Buy" rating for the company, marking the first coverage of the stock [2]. Core Insights - The introduction of professional managers has aided the company's reform, with product structure optimization driving profit improvement. The company has a rich product matrix in functional sugars and nutritional supplements, and has successfully adjusted its operational strategies during industry downturns, leading to a significant rebound in profit and gross margin improvement [1]. - The company stands to benefit from anti-dumping measures on erythritol and is positioned to capture the growing domestic market for allulose. With a production capacity of 30,000 tons per year, the company is expected to see volume and price increases in the European market due to its favorable anti-dumping tax rate [1]. - In 2024, all major segments achieved growth in both sales volume and gross margin, with a net profit of 111 million yuan, a year-on-year increase of 106%. The company has set ambitious performance targets for its stock incentive plan, reflecting confidence in future growth [1]. Summary by Sections Company Overview - Founded in 1997, the company is a leading player in the functional sugar industry in China, focusing on the research and production of biological (multi)sugars. It has established strategic partnerships with global giants like Coca-Cola and Yili, and has a comprehensive product system covering various functional sugars [18][21]. Management and Strategy - The company has undergone significant management restructuring, bringing in experienced professionals to enhance strategic planning and operational efficiency. The management team now combines international experience with local insights, which is expected to strengthen the company's competitive position in the functional sugar sector [24][25]. Financial Performance - The company forecasts net profits of 181 million, 216 million, and 260 million yuan for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 20.07, 16.82, and 13.99 times. This indicates a strong growth trajectory compared to industry averages [2][12]. Product Segments - The company has diversified its product offerings, including prebiotics, dietary fibers, and sugar substitutes, which are experiencing rapid growth in demand. The market for these products is expected to expand significantly, driven by increasing consumer health awareness [1][7][23]. Market Outlook - The report highlights the potential for growth in the allulose market and the stability of the erythritol market, suggesting that the company is well-positioned to capitalize on these trends. The anticipated approval of allulose in China is expected to open up new market opportunities [1][10].

Investment Rating - The investment rating for the company is "Buy" [4] Core Views - The company reported a revenue of 640 million yuan in Q1 2025, representing a year-on-year growth of 23%, and a net profit attributable to shareholders of 86 million yuan, which is a 69% increase year-on-year [1] - In 2024, the company achieved a revenue of 2.98 billion yuan, up 39% year-on-year, and a net profit of 430 million yuan, reflecting a 54% year-on-year growth [1] - The company’s sales net profit margin for 2024 was 14.5%, an increase of 1.4 percentage points year-on-year, and the weighted ROE was 14.2%, up 2.6 percentage points year-on-year [1] - The revenue from electric golf carts grew over 9 times in 2024, while electric bicycles and off-road motorcycles saw growth rates exceeding 40% [1] Summary by Sections Financial Performance - In Q1 2025, the company achieved a revenue of 640 million yuan and a net profit of 86 million yuan, marking a 23% and 69% increase year-on-year respectively [1] - For the full year 2024, the company reported a revenue of 2.98 billion yuan and a net profit of 430 million yuan, with year-on-year growth rates of 39% and 54% respectively [1] - The company’s sales net profit margin for 2024 was 14.5%, and the weighted ROE was 14.2% [1] Product Segments - The revenue from smart electric low-speed vehicles in 2024 was 1.89 billion yuan, a 48% increase year-on-year, with electric golf carts contributing 810 million yuan, a staggering 935% increase [2] - The revenue from special vehicles in 2024 was 920 million yuan, with all-terrain vehicles generating 740 million yuan (up 19%) and off-road motorcycles generating 190 million yuan (up 52%) [2] Market Position and Strategy - The company is expected to strengthen its market position as the competitive landscape improves, with its market share likely to increase despite challenges in exports to the U.S. due to high tariffs [3] - The company has established a leading position in overseas production capacity, with factories planned in the U.S., Vietnam, and Thailand, enhancing its core competitiveness [3] Earnings Forecast and Valuation - The company’s projected revenues for 2025, 2026, and 2027 are 3.79 billion yuan, 4.52 billion yuan, and 5.30 billion yuan, respectively, with year-on-year growth rates of 27%, 19%, and 17% [4] - The net profit attributable to shareholders is expected to be 573 million yuan, 692 million yuan, and 826 million yuan for the same years, with growth rates of 33%, 21%, and 19% respectively [4]

证券研究报告 | 浙商早知道 浙商早知道 2025 年 05 月 09 日 ： 张延兵 执业证书编号：S1230511010020 ： 021-80106048 ： zhangyanbing@stocke.com.cn 市场总览 重要观点 http://www.stocke.com.cn 1/3 请务必阅读正文之后的免责条款部分 报告日期：2025 年 05 月 09 日 1、所在领域 固收 ❑ 大势：周四上证指数上涨 0.3%，沪深 300 上涨 0.6%，科创 50 下跌 0.4%，中证 1000 上涨 0.8%，创业板指上涨 1.7%，恒生指数上涨 0.4%。 ❑ 行业：周四表现最好的行业分别是通信（+2.6%)、国防军工（+2.6%)、电力设备（+1.6%)、银行（+1.1%)、机械 设备（+1.0%)，表现最差的行业分别是美容护理（-1.0%)、有色金属（-0.4%)、钢铁（-0.4%)、石油石化（- 0.3%)、交通运输（-0.2%)。 ❑ 资金：周四沪深两市总成交额为 12934 亿元，南下资金净流出 23.9 亿港元。 ❑ 【浙商固收 覃汉】债券市场专题研究：如何看待 507 一揽子货币政策措 ...

Investment Rating - The investment rating for the company is "Accumulate" [6] Core Views - The company is expected to see a profit turning point due to high profitability and gradual release of profit elasticity. The gross profit margin for 2024 is projected at 70.22%, a year-on-year decrease of 7.85 percentage points, primarily due to the lower margin impact from the consolidation of Fuli Instruments. The core products, chromatography fillers and chromatography media, maintain a gross profit margin of 81.56%, with a slight year-on-year decline of 2.39 percentage points. The company’s unique ability to self-produce core raw materials, microspheres, is expected to further highlight its competitive edge, supporting a high level of gross margin for core products [2][4]. Financial Performance - In 2024, the company achieved revenue of 782 million yuan, a year-on-year increase of 33.33%. The net profit attributable to the parent company was 82.84 million yuan, up 20.82% year-on-year. In Q1 2025, the company reported revenue of 189 million yuan, a year-on-year growth of 22.39%, and a net profit of 29.22 million yuan, reflecting a 72.98% increase year-on-year [9][11]. Growth Potential - The company is positioned to benefit from accelerated domestic substitution and its own product strength and platform-driven growth. The core business of chromatography fillers and chromatography media is expected to continue its growth trend, with Q1 2025 revenue reaching approximately 111 million yuan, a year-on-year increase of about 10.62%. The strategic focus on high-quality clients is anticipated to further enhance operational quality [4][9]. Earnings Forecast and Valuation - The company’s revenue is projected to reach 966 million yuan in 2025, with a year-on-year growth of 23.44%. The net profit attributable to the parent company is expected to be 139 million yuan, reflecting a significant year-on-year increase of 68.00%. The earnings per share (EPS) for 2025 is estimated at 0.34 yuan, with a price-to-earnings (P/E) ratio of 66 times based on the closing price on May 8, 2025 [4][11].

Investment Rating - The investment rating for the company is "Accumulate" [6] Core Views - The company is expected to see a profit turning point due to high profitability and gradual release of profit elasticity, despite a slight decline in gross margin to 70.22% in 2024 [2] - The company has a strong cash flow generation capability, with a net cash flow from operating activities of 133 million yuan in 2024, indicating good operational quality [3] - The company is positioned to benefit from domestic substitution trends and has built a unique "product + service" platform, which is expected to drive growth in the coming years [4] Summary by Sections Profitability - The gross margin for 2024 is projected at 70.22%, down 7.85 percentage points year-on-year, primarily due to the lower margin impact from the consolidation of Fuli Instruments. The core products, chromatography fillers and chromatography media, maintain a gross margin of 81.56%, with a slight year-on-year decline of 2.39 percentage points [2] - The company’s high R&D investment has led to a sufficient reserve of new products, which can help mitigate risks from intensified market competition [2] Operational Quality - The net cash flow from operating activities for 2024 is expected to be 133 million yuan, reflecting a year-on-year increase of 5.99%, indicating sustained operational quality [3] - The accounts receivable turnover days for 2024 are 117 days, shortened by approximately 14 days year-on-year, while the first quarter of 2025 shows an increase to 145 days, likely due to a higher proportion of longer-term instrument products [3] Earnings Forecast and Valuation - The company is expected to achieve revenues of 966 million yuan in 2025, growing by 23.44% year-on-year, and a net profit attributable to shareholders of 139 million yuan, representing a growth of 68.00% [4] - The projected earnings per share (EPS) for 2025 is 0.34 yuan, with a price-to-earnings (P/E) ratio of 66 times based on the closing price on May 8, 2025 [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Insights - The company's performance in Q1 2025 shows resilience with a revenue increase of 25% and a profit increase of 44%, despite a challenging 2024 impacted by asset impairment [1][3] - The revenue structure indicates a shift towards traditional gold, while fashion jewelry and leather goods face pressure; however, the franchise business is experiencing significant growth [1][2] - The company is expected to maintain a strong growth trajectory, with revenue forecasts of 81 billion, 92 billion, and 103 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 24%, 14%, and 11% [3][4] Revenue and Profit Analysis - In 2024, the company reported a revenue of 6.52 billion (up 10.5% year-on-year) and a net profit of 194 million (down 42% year-on-year) due to impairment losses [1][4] - For Q4 2024, the revenue was 1.66 billion (up 18.4% year-on-year), but the net profit turned negative at -120 million, primarily due to a 210 million asset impairment loss [1] Store Expansion and Market Position - The company expanded its store count by 129 in 2024, reaching a total of 1,505 stores, with a notable increase in franchise stores [2] - The average GMV for franchise stores showed double-digit growth, indicating strong confidence among franchisees in the brand [2] Financial Forecasts - The company is projected to achieve a net profit of 4.8 billion, 5.6 billion, and 6.4 billion for 2025, 2026, and 2027 respectively, with corresponding year-on-year growth rates of 148%, 17%, and 15% [3][4] - The expected P/E ratios for the next three years are 17.5, 15.0, and 13.1 [3][4] Profitability Metrics - The gross margin for 2024 was 23.6%, down 2.5 percentage points year-on-year, while the net profit margin improved to 3.0% [10] - In Q1 2025, the gross margin was 22.9%, down 2.0 percentage points year-on-year, but the net profit margin increased to 8.4% [10]

25Q1 业绩扭亏，卫星业务占比持续提升 ——上海瀚讯 2024 年年报&2025 年一季报点评报告 投资要点 ❑ 25Q1 业绩扭亏，毛利率受产品结构影响 2024 年，公司实现营收 3.53 亿元，同比+13%，归母净利润-1.24 亿元。毛利率为 43.28%，同比-0.06pct。费用端稳中有降，销售/管理/研发/财务费用合计为 2.67 亿元，同比-19%。 25Q1，公司实现营收 1.26 亿元，同比+84%，归母净利润 0.13 亿元，同比扭亏为 盈。毛利率为 37.56%，同比-27.55pct，我们预计主要由于公司产品结构变化，卫 星业务占比增加影响整体毛利率表现。 ❑ 深度参与千帆星座建设，卫星业务已成为公司重要收入来源 ❑ 盈利预测与估值 公司是特种宽带通信龙头，前瞻布局卫星通信领域，考虑到短期客户订单节奏， 我们预计公司 2025-2027 年归母净利润为 1.05 亿元/2.46 亿元/4.46 亿元，对应 25 年 PE 为 129，公司积极打造卫星新成长点，维持"买入"评级。 ❑ 风险提示 军用宽带市场发展不及预期；市场竞争加剧的风险；卫星互联网发展不及预期 上海瀚讯(30076 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [7] Core Views - The company has experienced rapid growth in Q1 2025, with a revenue increase of 40.5% year-on-year, driven by its dual-engine strategy in telecommunications and data communication [1] - The data communication segment is expected to continue growing, with significant demand for CW laser chips in AI data centers, leading to a forecasted increase in sales from $800 million in 2023 to over $3 billion by 2029 [3] - The telecommunications business is optimizing its product structure, with a revenue increase of 52% year-on-year, and has successfully shipped next-generation 25G/50G PON optical chips [4] - The company maintains high R&D investment, with a 76.17% increase in R&D spending in 2024, focusing on high-speed optical chips and large-power laser chips [5] - Profit forecasts indicate a net profit of 1.04 billion yuan in 2025, with a projected PE ratio of 109X, reflecting the company's leading position in the industry and the expected ramp-up of multiple data communication products [6] Summary by Sections Financial Performance - In 2024, the company reported a revenue of 252 million yuan, a year-on-year increase of 74.6%, with a gross margin of 33.32% [1] - For Q1 2025, the company achieved a revenue of 84 million yuan, a 40.5% increase year-on-year, and a net profit of 14 million yuan, up 35.9% [1] Data Communication Business - The data center and other businesses generated a revenue of 48.04 million yuan in 2024, a staggering 919% increase year-on-year, with a gross margin of 71.04% [2] - The company successfully mass-produced CW70mW laser chips, achieving over one million units shipped within the year [2] Telecommunications Business - The telecommunications segment generated a revenue of 202 million yuan in 2024, a 52% increase year-on-year, with a gross margin of 24.62% [4] - The company has optimized its product offerings, increasing orders for 10G EML products significantly [4] Research and Development - The company invested 54.52 million yuan in R&D in 2024, a 76.17% increase, focusing on advanced optical chip technologies [5] Profit Forecasts - The company forecasts net profits of 1.04 billion yuan in 2025, 1.6 billion yuan in 2026, and 2.48 billion yuan in 2027, with corresponding PE ratios of 109X, 70.78X, and 45.77X [6]